RAD BioMed

An Israeli evergreen fund and accelerator for early-stage life science companies.

Incubator Active Tel Aviv-Yafo, Israel Est. 2011
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
A Round, Seed

About

RAD BioMed is an Israeli evergreen fund and accelerator that invests in and nurtures early-stage life science companies. It provides funding, mentorship, business development, marketing, HR, administration services, and state-of-the-art facilities to help startups in medical devices, biopharma, and synthetic biology. The accelerator aims to de-risk the startup process and support companies from concept to commercialization, addressing the funding gap for promising Israeli startups. RAD BioMed is part of the RAD-Bynet Group and focuses on disruptive solutions for unmet clinical needs.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

5 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences15
Education & Knowledge Technologies1

Q&A

What is RAD BioMed's primary investment focus?
RAD BioMed is an Israel-based private incubator that invests in early-stage biomedical and Hi-Tech start-ups. Their portfolio shows a strong concentration in Health Tech & Life Sciences.
Can you name some of RAD BioMed's recent notable exits?
RAD BioMed has had two significant exits recently. In July 2024, BELKIN Vision was acquired by Alcon Pharmaceuticals for $81M. Additionally, in September 2025, Vectorious Medical Technologies was acquired by Edwards Lifesciences for $497M.
What stages of investment does RAD BioMed typically engage in?
RAD BioMed primarily invests in Seed and A Round stages. According to startupim data, they have made 9 Seed investments and 3 A Round investments.
Who are the co-founders of RAD BioMed?
RAD BioMed was co-founded by Yehuda Zisapel and Nava Zisapel. Nava Zisapel also serves as the Chairperson.
Which portfolio companies have received B Round funding with RAD BioMed's involvement?
FEMSelect, a company focused on treatment for pelvic floor ligament fixation, has received B Round funding, raising $16.89M.
What is the most recent investment round RAD BioMed participated in?
The most recent investment round RAD BioMed participated in was in October 2022.
What kind of support does RAD BioMed provide to its portfolio companies?
RAD BioMed provides a full set of operational and professional services, mentorship, and industry connections to its early-stage portfolio companies.
Can you name a portfolio company of RAD BioMed that focuses on neurovascular disorders?
Perflow Medical is a portfolio company of RAD BioMed that develops medical devices to control neurovascular disorders. They have raised $13.6M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)